Cancer stem cells as 'units of selection'

被引：63

作者：

Greaves, Mel ^{[1
]}

机构：

[1] Inst Canc Res, Haematooncol Res Unit, Div Mol Pathol, Sutton SM2 5NG, Surrey, England

来源：

EVOLUTIONARY APPLICATIONS | 2013年 / 6卷 / 01期

关键词：

disease Biology; evolutionary Medicine; natural selection and contemporary evolution; ACQUIRED-RESISTANCE; CLONAL EVOLUTION; MYELOID-LEUKEMIA; MUTATION; DISEASE; GROWTH; HETEROGENEITY; DIAGNOSIS; IMATINIB; HISTORY;

D O I：

10.1111/eva.12017

中图分类号：

Q [生物科学];

学科分类号：

090105 [作物生产系统与生态工程];

摘要：

Cancer development is widely recognized to be a somatic cell evolutionary process with complex dynamics and highly variable time frames. Variant cells and descendent subclones gain competitive advantage via their fitness in relation to micro-environmental selective pressures. In this context, the unit of selection is the cell, but not any cell. The so-called cancer stem cells have the essential properties required to function as the key units of selection, particularly with respect to their proliferative potential and longevity. These cells drive evolutionary progression of disease and provide reservoirs for relapse or recurrence and drug resistance. They represent the prime, but elusive and moving, targets for therapeutic control.

引用

页码：102 / 108

页数：7

共 73 条

[1]

Genetic variegation of clonal architecture and propagating cells in leukaemia [J].

Anderson, Kristina ;

Lutz, Christoph ;

van Delft, Frederik W. ;

Bateman, Caroline M. ;

Guo, Yanping ;

Colman, Susan M. ;

Kempski, Helena ;

Moorman, Anthony V. ;

Titley, Ian ;

Swansbury, John ;

Kearney, Lyndal ;

Enver, Tariq ;

Greaves, Mel .

NATURE, 2011, 469 (7330) :356-+

[2]

[Anonymous], GENES ORGANISMS POPU

[3]

[Anonymous], 2008, Evolution and the levels of selection, DOI DOI 10.1093/ACPROF:OSO/9780199267972.001.0001

[4]

[Anonymous], 2010, The immortal life of Henrietta Lacks

[5]

[Anonymous], 1992, Natural Selection: domains, levels, and challenges

[6]

Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor - Mutant lung adenocarcinomas with acquired resistance to kinase inhibitors [J].

Balak, Marissa N. ;

Gong, Yixuan ;

Riely, Gregory J. ;

Somwar, Romel ;

Li, Allan R. ;

Zakowski, Maureen F. ;

Chiang, Anne ;

Yang, Guangli ;

Ouerfelli, Ouathek ;

Kris, Mark G. ;

Ladanyi, Marc ;

Miller, Vincent A. ;

Pao, William .

CLINICAL CANCER RESEARCH, 2006, 12 (21) :6494-6501

[7]

Carcinogen-specific induction of genetic instability [J].

Bardelli, A ;

Cahill, CP ;

Lederer, G ;

Speicher, MR ;

Kinzler, KW ;

Vogelstein, B ;

Lengauer, C .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) :5770-5775

[8]

A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours [J].

Beck, Benjamin ;

Driessens, Gregory ;

Goossens, Steven ;

Youssef, Khalil Kass ;

Kuchnio, Anna ;

Caauwe, Amelie ;

Sotiropoulou, Panagiota A. ;

Loges, Sonja ;

Lapouge, Gaelle ;

Candi, Aurelie ;

Mascre, Guilhem ;

Drogat, Benjamin ;

Dekoninck, Sophie ;

Haigh, Jody J. ;

Carmeliet, Peter ;

Blanpain, Cedric .

NATURE, 2011, 478 (7369) :399-+

[9]

Signatures of mutation and selection in the cancer genome [J].

Bignell, Graham R. ;

Greenman, Chris D. ;

Davies, Helen ;

Butler, Adam P. ;

Edkins, Sarah ;

Andrews, Jenny M. ;

Buck, Gemma ;

Chen, Lina ;

Beare, David ;

Latimer, Calli ;

Widaa, Sara ;

Hinton, Jonathon ;

Fahey, Ciara ;

Fu, Beiyuan ;

Swamy, Sajani ;

Dalgliesh, Gillian L. ;

Teh, Bin T. ;

Deloukas, Panos ;

Yang, Fengtang ;

Campbell, Peter J. ;

Futreal, P. Andrew ;

Stratton, Michael R. .

NATURE, 2010, 463 (7283) :893-U61

[10]

Telomeres and human disease: Ageing, cancer and beyond [J].

Blasco, MA .

NATURE REVIEWS GENETICS, 2005, 6 (08) :611-622

← 1 2 3 4 5 6 7 8 →